Authors: Akhan, SE Kilic, G Salihoglu, Y Bengisu, E Berkman, S

Citation: Se. Akhan et al., Nongenital metastatic cancers of the ovary: A clinical analysis, EUR J GYN O, 22(5), 2001, pp. 379-383

Authors: Topuz, E Eralp, Y Saip, P Aydiner, A Tas, F Salihoglu, Y Berkman, S Bengisu, E

Citation: E. Topuz et al., The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage IC ovarian carcinoma, EUR J GYN O, 22(1), 2001, pp. 70-73

Authors: Salihoglu, Y Bilir, A Aydiner, A Erkan, M Tuzlali, S Eralp, Y

Citation: Y. Salihoglu et al., Thymidine labeling index in epithelial ovarian cancer, INT J GYN O, 75(2), 2001, pp. 171-176

Authors: Topuz, E Aydiner, A Saip, P Eralp, Y Tas, F Salihoglu, Y Tenekeci, N

Citation: E. Topuz et al., Correlations of serum CA125 level and computerized tomography (CT) imagingwith laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer, EUR J GYN O, 21(6), 2000, pp. 599-602

Authors: Topuz, E Salihoglu, Y Aydiner, A Saip, P Tas, F Sozen, T Berkman, S Bengisu, E

Citation: E. Topuz et al., Celsite (R) port and catheter as an intraperitoneal access device in the treatment of ovarian cancer, J SURG ONC, 74(3), 2000, pp. 223-226

Authors: Topuz, E Saip, P Aydiner, A Salihoglu, Y Aydin, Y Topuzlu, C

Citation: E. Topuz et al., Catheter complications associated with intraperitoneal chemotherapy (vol 19, pg 275, 1998), EUR J GYN O, 19(5), 1998, pp. 430-430